Literature DB >> 30512204

Illicit fentanyls in the opioid street market: desired or imposed?

Sarah G Mars1, Daniel Rosenblum2, Daniel Ciccarone1.   

Abstract

BACKGROUND: Illicitly manufactured fentanyl and its analogues are appearing in countries throughout the world, often disguised as heroin or counterfeit prescription pills, with resulting high overdose mortality. Possible explanations for this phenomenon include reduced costs and risks to heroin suppliers, heroin shortages, user preferences for a strong, fast-acting opioid and the emergence of Dark Web cryptomarkets. This paper addresses these potential causes and asks three questions: (1) can users identify fentanyl; (2) do users desire fentanyl; and (3) if users want fentanyl, can they express this demand in a way that influences the supply? ARGUMENT/ANALYSIS: Existing evidence, while limited, suggests that some users can identify fentanyl, although not reliably, and some desire it, but because fentanyl is frequently marketed deceptively as other drugs, users lack information and choice to express demand effectively. Even when aware of fentanyl's presence, drug users may lack fentanyl-free alternatives. Cryptomarkets, while difficult to quantify, appear to offer buyers greater information and competition than offline markets. However, access barriers and patterns of fentanyl-related health consequences make cryptomarkets unlikely sources of user influence on the fentanyl supply. Market condition data indicate heroin supply shocks and shortages prior to the introduction of fentanyl in the United States and parts of Europe, but the much lower production cost of fentanyl compared with heroin may be a more significant factor
CONCLUSION: Current evidence points to a supply-led addition of fentanyl to the drug market in response to heroin supply shocks and shortages, changing prescription opioid availability and/or reduced costs and risks to suppliers. Current drug users in affected regions of the United States, Canada and Europe appear largely to lack both concrete knowledge of fentanyl's presence in the drugs they buy and access to fentanyl-free alternatives.
© 2018 Society for the Study of Addiction.

Entities:  

Keywords:  Demand-led; fentanyl; heroin; illicit opioids; markets; prescription opioids; supply shock; supply-led

Mesh:

Substances:

Year:  2018        PMID: 30512204      PMCID: PMC6548693          DOI: 10.1111/add.14474

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  38 in total

1.  Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone.

Authors:  Irfan A Dhalla; Muhammad M Mamdani; Marco L A Sivilotti; Alex Kopp; Omar Qureshi; David N Juurlink
Journal:  CMAJ       Date:  2009-12-07       Impact factor: 8.262

2.  Fentanyl in the US heroin supply: A rapidly changing risk environment.

Authors:  Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2017-07-20

3.  Today's fentanyl crisis: Prohibition's Iron Law, revisited.

Authors:  Leo Beletsky; Corey S Davis
Journal:  Int J Drug Policy       Date:  2017-07-18

Review 4.  A review: Fentanyl and non-pharmaceutical fentanyls.

Authors:  Joji Suzuki; Saria El-Haddad
Journal:  Drug Alcohol Depend       Date:  2016-12-16       Impact factor: 4.492

5.  Trends in fentanyl prescriptions and fentanyl-related mortality in Australia.

Authors:  Amanda Roxburgh; Lucy Burns; Olaf H Drummer; Jennifer Pilgrim; Michael Farrell; Louisa Degenhardt
Journal:  Drug Alcohol Rev       Date:  2013-02-26

6.  The Textures of Heroin: User Perspectives on "Black Tar" and Powder Heroin in Two U.S. Cities.

Authors:  Sarah G Mars; Philippe Bourgois; George Karandinos; Fernando Montero; Daniel Ciccarone
Journal:  J Psychoactive Drugs       Date:  2016-07-20

7.  Impact of South American heroin on the US heroin market 1993-2004.

Authors:  Daniel Ciccarone; George J Unick; Allison Kraus
Journal:  Int J Drug Policy       Date:  2009-02-06

8.  Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis.

Authors:  Nicholas Baldwin; Roger Gray; Anirudh Goel; Evan Wood; Jane A Buxton; Launette Marie Rieb
Journal:  Drug Alcohol Depend       Date:  2018-02-20       Impact factor: 4.492

9.  Characteristics of Fentanyl Overdose - Massachusetts, 2014-2016.

Authors:  Nicholas J Somerville; Julie O'Donnell; R Matthew Gladden; Jon E Zibbell; Traci C Green; Morgan Younkin; Sarah Ruiz; Hermik Babakhanlou-Chase; Miranda Chan; Barry P Callis; Janet Kuramoto-Crawford; Henry M Nields; Alexander Y Walley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-04-14       Impact factor: 17.586

10.  High willingness to use rapid fentanyl test strips among young adults who use drugs.

Authors:  Maxwell S Krieger; Jesse L Yedinak; Jane A Buxton; Mark Lysyshyn; Edward Bernstein; Josiah D Rich; Traci C Green; Scott E Hadland; Brandon D L Marshall
Journal:  Harm Reduct J       Date:  2018-02-08
View more
  36 in total

1.  Vaccine blunts fentanyl potency in male rhesus monkeys.

Authors:  Rebekah D Tenney; Steven Blake; Paul T Bremer; Bin Zhou; Candy S Hwang; Justin L Poklis; Kim D Janda; Matthew L Banks
Journal:  Neuropharmacology       Date:  2019-07-29       Impact factor: 5.250

2.  The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis.

Authors:  Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2019-02-02

3.  Fentanyl Preference among People Who Inject Drugs in West Virginia.

Authors:  Alyona Mazhnaya; Allison O'Rourke; Rebecca Hamilton White; Ju Nyeong Park; Michael E Kilkenny; Susan G Sherman; Sean T Allen
Journal:  Subst Use Misuse       Date:  2020-05-22       Impact factor: 2.164

4.  Toward the Interpretation of Positive Testing for Fentanyl and Its Analogs in Real Hair Samples: Preliminary Considerations.

Authors:  A Salomone; R Bigiarini; J J Palamar; C McKnight; L Vinsick; E Amante; D Di Corcia; M Vincenti
Journal:  J Anal Toxicol       Date:  2020-05-18       Impact factor: 3.367

5.  The Rapidly Changing US Illicit Drug Market and the Potential for an Improved Early Warning System: Evidence from Ohio Drug Crime Labs.

Authors:  Daniel Rosenblum; Jay Unick; Daniel Ciccarone
Journal:  Drug Alcohol Depend       Date:  2020-01-07       Impact factor: 4.492

6.  Characteristics Associated with Nonmedical Methadone Use among People Who Inject Drugs in California.

Authors:  Johnathan K Zhao; Alex H Kral; Lynn D Wenger; Ricky N Bluthenthal
Journal:  Subst Use Misuse       Date:  2019-10-14       Impact factor: 2.164

7.  Understanding the increase in opioid overdoses in New Hampshire: A rapid epidemiologic assessment.

Authors:  Andrea Meier; Sarah K Moore; Elizabeth C Saunders; Bethany McLeman; Stephen A Metcalf; Samantha Auty; Olivia Walsh; Lisa A Marsch
Journal:  Drug Alcohol Depend       Date:  2020-02-07       Impact factor: 4.492

8.  Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs.

Authors:  Ricky N Bluthenthal; Kelsey Simpson; Rachel Carmen Ceasar; Johnathan Zhao; Lynn Wenger; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2020-03-18       Impact factor: 4.492

9.  High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone.

Authors:  Yu Chen; Huyen T N Tran; Yasir H Saber; F Scott Hall
Journal:  Pharmacol Biochem Behav       Date:  2020-03-19       Impact factor: 3.533

10.  The protective effect of trusted dealers against opioid overdose in the U.S.

Authors:  Jennifer J Carroll; Josiah D Rich; Traci C Green
Journal:  Int J Drug Policy       Date:  2020-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.